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SUMMARY 
The last decade has seen a huge increase in the amount of ³omics´ data available and 
in our ability to interpret those data. The aim of this paper is to consider how omics 
techniques can be used to improve and refine microbiological risk assessment, using 
dose response models for RNA viruses, with particular reference to norovirus through 
the oral route as the case study. The dose response model for initial infection in the 
gastrointestinal tract is broken down into the component steps at the molecular level 
and the feasibility of assigning probabilities to each step assessed. The molecular 
mechanisms are not sufficiently well understood at present to enable quantitative 
estimation of probabilities on the basis of omics data. At present, the great strength of 
gene sequence data appears to be in giving information on the distribution and 
proportion of susceptible genotypes (for example due to the presence of the 
appropriate pathogen-binding receptor) in the host population rather than in predicting 
specificities from the amino acid sequences concurrently obtained. The nature of the 
mutant spectrum in RNA viruses greatly complicates the application of omics 
approaches to development of mechanistic dose response models and prevents 
prediction of risks of disease progression (given infection has occurred) at the level of 
the individual host. However, molecular markers in the host and virus may enable 
more broad predictions to be made about the consequences of exposure in a 
population. In an alternative approach, comparing the results of deep sequencing of 
RNA viruses in the faeces/vomitus from donor humans with those from their infected 
recipients may enable direct estimates of the average probability of infection per 
virion to be made. 
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INTRODUCTION 
Classical microbiological risk assessments (MRAs) consist of four steps: hazard 
identification, hazard characterisation, exposure assessment and risk characterisation 
(CAC 1999). There is now a wealth of literature on this subject and MRAs have been 
developed for many pathogen/commodity combinations spanning a wide range of 
food types from ready-to-eat produce to animal products cooked in the home (e.g. 
Cassin et al., 1998; Gale, 2005; Nauta et al., 2007). Despite their potential 
contribution to MRA, the use of ³omics´ data in MRA has to date been limited. 
Therefore, the aims of this paper are to elucidate how omics data and the techniques 
used to generate and analyse such data can be used to improve and/or complement 
MRA, to identify where barriers may exist to the incorporation of omics data into 
MRA, and to consider where future omics data may prove useful. The focus is on the 
human oral dose response relationship (DRR) not only because some of the molecular 
processes governing the pathogen/host interaction are established, but also because 
there are known data gaps in the DRR for many pathogen/commodity combinations. 
The DRR is used to translate the exposure through the oral route into a risk of 
infection/disease. In classical MRAs, the DRR is based on human studies where 
different doses are fed to groups of volunteers (Ward et al., 1986) and the proportion 
infected (or ill) at each dose is plotted against the dose. Mathematical models are then 
fitted to those data and used to predict the probability of infection for doses not 
included in the volunteer study (Teunis et al., 2008; Haas et al., 1993). 
Over the last decade there has been a huge increase in the amount of omics data 
available and in our ability to interpret those data using bioinformatics techniques.  
For genomics, the introduction of high-throughput next generation sequencing (NGS) 
technologies in 2005 greatly increased the capability to sequence whole genomes 
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from individual living organisms rapidly and cheaply, providing information on 
variation across the host population (Pareek et al., 2011). NGS has also enabled the 
³deep-sequencing´ of viral genomes and effectively gives the sequence of every virus 
in the exposure dose in terms of a mutant spectrum (Bull et al., 2012). Proteomics 
allows the identification of those proteins important to the cell in any given situation 
(Neidhardt, 2011). The relative proportions of proteins represent the protein signature 
which changes in response to a challenge and could be used to identify proteins 
expressed in a host cell in response to infection by a virus, for example. The great 
potential of proteomics is to be able to detect previously unknown proteins and assign 
their cellular location and their contacts with other proteins (Marchadier et al., 2011). 
Another approach which is considered here is ³JO\FRSURWHRPLFV´ Many proteins, 
particularly those on cell or pathogen surfaces and in the host immune system, have 
sugar units, called glycans, added to them. Indeed these glycans serve as receptors on 
cell surfaces for a number of pathogens including norovirus (NoV). Glycoproteomics 
characterises proteins containing glycans. Glycosylation (the synthesis of glycans) 
still remains practically unexplored at the proteome scale (Doerr 2012). 
There are relatively few pathogens for which human volunteer dose response data are 
available, and in general such data are absent for newly emerged pathogens. While 
animal models have been used together with calibration from human outbreak data 
(Teunis et al., 2004), other techniques are needed to obtain DRR parameters. 
Furthermore, account needs to be taken of the more susceptible members of the 
human population. The focus of the first part of this paper is on the development of a 
mechanistic dose response model for estimating the probability of initial infection 
through the oral route. The second part of this paper considers the exciting possibility 
that NGS data of virus isolated from donor and recipient human cases may facilitate a 
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direct estimation of the probability of initial infection. The final part addresses the 
problems in applying omics approaches to predicting disease progression and spread 
to other tissues once infection has established in the gastrointestinal tract. NoV is 
selected as an example to demonstrate the concepts because there are dose response 
data from human volunteer studies (Teunis et al., 2008) together with a wealth of 
molecular information on receptor binding for this pathogen.  
AN OMICS-BASED APPROACH FOR ESTIMATING THE PROBABILITY 
OF INITIAL INFECTION BY VIRUS IN ORAL EXPOSURE 
Infection by an oral pathogen is defined as the multiplication of organisms within the 
host, followed by excretion (Haas et al 1999). Biologically, the infection process for a 
virus such as NoV is comprised of a number of steps as set out in Table 1. Each 
pathogen particle of genomic form i, has a probability pij of initiating infection in a 
host individual of genomic form, j. The probability, pij, is expressed as:- 
Equation 1: ࢖࢏࢐ ൌ ࢌሺ࢖૚࢏࢐ǡ ࢖૛࢏࢐ǡ ࢖૜࢏࢐ǡ ࢖૝࢏࢐ሻ  
where each pxij is the probability of a virus particle i completing the step x of the four 
steps (Table 1) in human j. Calculating pij for every j in the host population and every 
i in the virus population would allow definition of the DRR for initial infection if the 
relative proportions of each genomic form in the virus and human populations were 
known. With NGS, it is conceivable that gene sequences for at least some js and most 
is could be available in the future, thus giving the relative proportions of genomic 
forms. The data required and feasibility of assigning a quantitative probability to pxij 
for steps 1 to 4 in Table 1 are now discussed using NoV as the primary case study. 
Probability of pathogen overcoming the immediate host defences to reach its 
cellular receptor 
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There are a number of immediate host defences in the mouth and gastrointestinal tract 
including the mucus barrier, microbial interference, decoy receptors and the innate 
immune system. The histoblood group antigens (HBGAs) are glycans to which certain 
viruses, including NoV and rotavirus, selectively bind. HBGAs are present on both 
decoy receptors in the saliva and on mucin, the main protein component of mucus 
(Boshuizen et al., 2005; Huang et al., 2009; McGuckin et al., 2011). Shanker et al. 
(2011) propose that local flexibility in the viral capsid protein could allow the NoV to 
disassociate from salivary HBGA due to the pH change during its passage through the 
gastrointestinal tract. However, the molecular mechanism is not understood, and the 
problem for estimation of p1 is that the effect of pH on protein structure is going to be 
very difficult to predict from gene sequences. A further complication is that while 
mucin production is increased during rotavirus infection through a mechanism 
involving the innate immune system, other pathogens such as Helicobacter pylori 
suppress synthesis of gastric mucin (McGuckin et al., 2011). Thus information on p1 
from one pathogen cannot be applied to another. Mucin glycosylation patterns change 
with age of the host altering the antiviral capabilities (McGuckin et al., 2011; 
Boshuizen et al., 2005) but providing a molecular basis for understanding of variation 
in p1 with age of the host. 
The gastrointestinal tract microbiota prevent enteric disease by pathogens, including 
rotavirus, a trait referred to as colonisation resistance or microbial interference 
(Wardwell et al., 2011). However, the relationship between gastrointestinal viruses 
and commensal bacteria or how gut microbial populations affect infection by enteric 
viruses is not well understood (Wardwell et al., 2011). Interestingly, the microbiota 
modulate mucin production and glycosylation (McGuckin et al., 2011) and therefore 
indirectly affect p1. Sequencing the human microbiome ZLOOSURYLGHD³GHHS´JHQHWLF
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perspective on individual bacteria (HMP, 2012) thus shedding light on the host-
pathogen-microbiome interaction, although it will be difficult to translate this into an 
estimate of p1. 
The innate immune system provides an immediate defense for the host against 
pathogens in a non-specific and generic manner. Central to the innate immune system 
is the recognition of specific, repeating structures (pathogen-associated molecular 
patterns or PAMPs) on the pathogen by the pathogen recognition receptors (PRRs) of 
the host (de Koning et al., 2012). A goal towards developing a mechanistic DRR 
would be to predict whether PAMPs on a given pathogen could be detected by the 
PRRs in a given host j. This requires an understanding of the molecular structure of 
the PRR in combination with its PAMP ligand. Crystal structures of PRR proteins 
complexed with pathogen PAMP ligands have been published (Takeuchi and Akira 
2010) and in combination with genomics data could assist in predicting the strength of 
binding in different individuals. However, predicting effects of changes in gene 
sequence on binding may not be straightforward because although polymorphisms in 
host PRR genes attenuate recognition of pathogen PAMP ligands, the amino acids 
corresponding to these polymorphisms do not seem to directly contact the ligand 
molecules themselves in the case of Salmonella flagellin at least (Uenishi et al., 
2012). Indeed, the differences may be subtle because it is not yet understood how the 
innate immune system distinguishes commensal bacteria from pathogenic bacteria, 
i.e. friend or foe (de Koning et al., 2012). Furthermore, there are numerous PRRs with 
each recognising different parts of the virus (Triantafilou et al., 2011) giving 
alternative pathways which will greatly complicate the estimation of the probability of 
a virus escaping the innate immue system prior to binding to its cellular receptor in 
step 2. 
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Probability of binding of pathogen to its cellular receptor 
If the virus fails to bind to a receptor on a cell in the lumen of the gastrointestinal tract 
it will pass harmlessly through. The binding of virus to its receptor(s) on the host cell 
surface is a highly specific molecular interaction and controls host cell susceptibility 
and hence defines which cell types and tissues are infected (tissue tropism). The 
binding of NoV capsid protein to its HBGA receptor on the intestinal cells is well 
understood at the molecular level through X-ray crystallography studies (Choi et al., 
2008; Bu et al., 2008). The ultimate goal would be to predict pathogen binding on the 
basis of nucleotide sequences of the viral capsid protein and the known (or ultimately 
predicted) structures of the HBGA glycan receptors. However, despite high 
conservation of the amino acid residues of the viral capsid protein that interact with 
HBGA, sequence similarity is not a predictor of the HBGA binding pattern (Bull and 
White 2011). Indeed closely related capsids can display distinct HBGA binding 
patterns, whereas genetically unrelated capsids from separate genogroups can display 
comparable HBGA binding patterns (Bull and White 2011). This will complicate the 
application of omics approaches to predicting pathogen specificity from viral protein 
sequences, and hence estimating p2. Further complications are that structures of NoV 
from genogroups GI and GII in complex with HBGAs reveal different modes of 
interaction (Hansman et al., 2011) and NoVs recognise HBGAs in a distinct strain-
dependent manner (Shanker et al., 2011). The NoVs are constantly evolving with 
antigenic drift in the capsid protein giving different HBGA binding specificities 
(Shanker et al., 2011; Donaldson et al., 2008). Genomics data, together with crystal 
structure data, could be used to identify changes in surface moieties of viral capsids 
although interpretation of impact on function may be more difficult. An example of 
this has been observed by NGS of FMDV in laboratory-infected cattle (Wright et al., 
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2011). The laboratory strain of virus had several positively charged amino acids in its 
coat protein selected for by negatively-charged heparin sulphate in cell culture. In the 
cow those positive charges reverted. While rotavirus targets the intestinal epithelium, 
it is not known exactly which cells in the intestine NoV binds to (Chan et al., 2011). 
To develop a mechanistic DRR, it is a requirement to know which cells are targeted 
initially by the virus as different cells express different surface proteins. It is 
concluded that even for the best understood systems, prediction of p2 for individual 
virus i x human j interactions will be extremely difficult.  
Using genomics data to assess the proportion of host population which is resistant to 
virus on the basis of receptor binding in step 2. The genetics of resistance to NoV 
infection provides an excellent example of how genetic markers could be used for 
calibrating a mechanistic DRR. Lindesmith et al. (2003) reported that 29% of humans 
studied in one population were homozygous recessive for the FUT2 gene and were 
unable to synthesise a functional enzyme to make the glycan part of the HBGA 
receptor to which the NoV binds. These populations do not express the receptor 
required for NoV binding and are thus highly protected against NoV infection, i.e. p2 
| 0. Indeed, none of those individuals developed an infection after exposure, however 
large the dose of virus ingested. About 20% of Europeans are in this highly protected 
category (Kindberg and Svensson, 2009). De Rougemont et al. (2011) could not 
accurately calculate the dissociation constant for NoV and its HBGA receptor, 
although the association is likely to be strong. Thus, in the case of NoV, it may be 
possible to simplify step 2 into assuming that p2 o 1 for those individuals who are 
genetically susceptible in having a functional FUT2 gene, while p2 = 0 for those who 
are genetically resistant through having a non-functional FUT2 gene. This simplifies 
the calibration of p2 in the DRR into determining the proportion of the population 
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which is resistant, an application to which genomics approaches are particularly well 
suited. However, the possibility that the pathogen could use alternative receptors 
would need to be eliminated, as in the case of the bacterium H. pylori, which is 
known to use other carbohydrate receptors in addition to HBGA (de Mattos et al., 
2012) such that p2 is the sum of probabilities of parallel routes each with a different p 
value. 
The breakdown of volunteer dose response data of Ward et al. (1986) into a two 
component model has been proposed previously for rotavirus (Gale, 2005). However, 
unlike the case for NoV, there are limited molecular data on binding of rotavirus to its 
receptor or indeed on the genetic basis for variation between populations in 
susceptibility. Also, the binding process for rotavirus may be more complicated than 
for NoV with several cell-surface molecules implicated (Isa et al., 2008), and 
evidence that rotavirus surface protein may open up tight junctions between cells in 
the intestinal lumen allowing access for binding to the basal side of the cell (Nava et 
al., 2004; Boshuizen et al., 2005) in addition to the apical side of the cell used by 
NoV. Predicting such sequences of events would be difficult even if proteomics 
approaches identified the hubs of protein-protein inteactions involved. 
Probability of cell entry by the pathogen 
The probability of host cell entry (p3) by the virus (given it has bound to the cellular 
receptor in step 2) depends, for some viruses at least, on the efficiency of cleavage of 
a viral protein by a host cell proteolytic enzyme. This specific cleavage process 
typically occurs after the newly synthesised virions are released from the cells in the 
previous round of infection. The ability of the host FHOOV¶SURWHRO\WLFHQ]\PHVWR
cleave the viral proteins may control entry to the cell in the next round of infection, as 
in the case of highly pathogenic avian influenza virus, for which the tissue tropism 
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and pathogenicity are determined by whether the host cells¶ proteolytic enzymes can 
cleave the viral haemagglutinin protein. This explains the ability of highly pathogenic 
H5 and H7 avian influenza strains to replicate in many organs outside the respiratory 
tract thus defining their highly pathogenic phenotype (Chaipan et al., 2009). 
Predicting p3 depends in part on being able to predict whether the viral protein is not 
only specifically cleaved (i.e. in the right place) but also efficiently cleaved. This is 
more of a traditional biochemistry/bioinformatics problem dependent on 
understanding the structure of the virus protein and the mechanism/specificity of the 
host proteolytic enzymes. Thus, for example, Misasi et al. (2012) found that specific 
differences in the requirements of filoviruses for a host cell proteolytic enzyme (called 
cathepsin B) are correlated with sequence polymorphisms at residues 47 and 584 in 
the viral glycoproteins. The use of cathepsin proteases as host factors for virus entry is 
a general property of members of the filovirus family. Those authors were able to 
predict that a newly identified ebolavirus is cathepsin B dependent. This approach 
may be applicable to assessing cell entry requirements for other viruses in the future 
and would contribute to our understanding of p3 in different host cell types. In this 
respect the rate of cleavage in different tissues would affect the magntitude of p3. Cell 
entry by SARS coronavirus also requires cleavage of the virus spike protein by 
cellular cathepsin (Bosch et al., 2008). The mechanism of NoV entry is not clear 
although there is some evidence that a proteolytic process could be necessary for 
replication (Tan et al., 2006). 
Probability of replication within the host cell 
Isolation of viruses by cell culture relies on replication of the virus within the cells 
and using several types of cell culture provides a suitable environment for many 
viruses (Leland and Ginocchio 2007). Indeed, transgenic expression of the appropriate 
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receptor (step 2) may make a previously nonsusceptible cell susceptible (e.g. as for 
poliovirus, (PV)) (Leland and Ginocchio 2007). Thus the default position for step 4 
would be to assume that p4 o 1, and that viral RNA replication, capsid synthesis and 
assembly can occur in the host cell given the virus nucleoprotein core has gained 
entry through steps 2 and 3. Supporting this, replication of the viral RNA is performed 
by RNA dependent RNA polymerase (RdRp) present in the virus core and synthesis 
of new virus capsid proteins takes place on the host cell ribosomes. Indeed, viral 
proteins seize control of cellular translation factors and host signalling pathways not 
only ensuring viral proteins are produced but also stifling the innate host defences that 
limit the capacity of infected cells to produce virus (Walsh and Mohr 2011). 
Understanding the regulation of these pathways may enable refinement of the 
estimate of p4. Thus, viruses commonly use host cell survival mechanisms to their 
own advantage and in particular the PI3K/Akt pathway which suppresses apoptosis 
(programmed cell death) so giving time for completion of viral replication (Eden et 
al., 2011). Phosphorylation of NoV RdRp by the host Akt pathway decreases the 
polymerase activity (Eden et al., 2011), and may be an antiviral strategy which should 
be considered in estimating p4. Central to understanding virus replication in step 4 is 
the application of proteomics to determine protein-protein contacts in situ in the 
infected cell and thus how the individual virus proteins associate with host cell 
proteins and hence work together. It is envisaged that proteomic techniques could be 
used to identify hubs in virus-infected host cells in a similar way to those in the 
bacterium Bacillus subtilis (Marchadier et al., 2011). Of importance for assessing the 
infectivity of a virus in terms of the DRR is how each viral protein interacts with the 
host proteins in the different hubs, many of which correspond to regulatory pathways 
(Marchadier et al., 2011). A proteomic analysis (using mass spectrometry) of human 
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host proteins associated with the RdRp of H5N1 avian influenza virus identified 400 
proteins which may have a role in induction of apoptosis and in innate antiviral 
signalling or are cellular RNA polymerase accessory factors i.e. involved in 
regulation of gene expression in the cell (Bradel-Tretheway et al., 2011). Such 
proteomics data by identifying host cell proteins bound to viral polymerases and so 
defining protein hubs may enhance our understanding of virus replication and 
assembly, and would enable qualitative refinement of the estimation of the p4. 
USING DEEP SEQUENCING TO DIRECTLY DETERMINE THE 
PROBABILITY OF INFECTION FOR AN RNA VIRUS 
NoV is an example of an RNA virus. Indeed many viruses which infect humans, 
including PV, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), 
have RNA genomes and differ from DNA pathogens such as bacteria and protozoa in 
that the replication of the viral RNA during infection of a cell (step 4) is prone to error 
(Smidansky et al. 2008), so generating a cloud of mutants (i.e. the progeny virions 
differ in sequence, albeit by only one or two bases in 10,000). This is called a mutant 
spectrum and is central to quasispecies theory (Lauring and Andino 2010). The key 
point is that the individual viruses excreted by an infected person in faeces or in 
vomitus, and therefore present in an oral exposure, are slightly different in sequence, 
albeit related. NGS (or deep sequencing) provides sequences for all the viral variants 
in an exposure together with their relative frequencies (i.e. the mutant spectrum) and 
has been used to detect minority sequence variants for a number of human viruses 
(Wright et al., 2011). This is clearly an important first step for making predictions on 
the DRR. Indeed NGS of RNA viruses recovered from an infected person may give 
an indication of the number of virions that initiated the infection and has shown that 
in the case of HCV and HIV, infection arises from a single variant often representing 
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initial infection by one or a few viral particles (Wang et al. 2010; Bull et al. 2012). 
Moreover, the infection process may represent a bottleneck such that only one or two 
viral variants in the exposure dose successfully establish infection (Bull et al 2011). 
Thus in the case of NoV, only minor variants at frequencies as low as 0.01% were 
successfully transmitted to establish a new infection (Bull et al., 2012). This suggests 
the risk of infection from a NoV virion, on average, is ~0.0001 (assuming the 
exposure dose was high, which is likely through faeces or vomitus, such that the 
complete spectrum of variants was present). If every NoV had a high probability of 
infection, then Bull et al. (2012) would have seen a range of NoV sequences in the 
infected persons corresponding to most of the individual virions in the exposure dose. 
Indeed, the two major variants in the donor person accounted for 99% of the variants 
but were not present in either of the two recipient persons. Similarly, for HCV, only 
one or two viral variants successfully established infection (Wang et al., 2010; Bull et 
al., 2011). Wang et alZULWHWKDW³QRWKLQJLQRXUGDWDUXOHVRXWWKHSRVVLELOLW\
that many additional particles were in the initial inoculum but did not replicate in the 
QHZKRVW´ This raises the question of how many viruses were in the dose in the 
original exposure event but had very low, or even negligible, probabilities of infection 
due to the bottleneck. The number of foot-and-mouth disease virus (FMDV) RNA 
molecules/ml of serum measured in infected pigs by RT-PCR are three to four orders 
of magnitude higher than the numbers of plaque-forming units (pfu) measured by 
conventional methods (Rodriguez-Calvo et al., 7KXVHDFKSIX³GRVDJH´LQWKH
human rotavirus volunteer study (Ward et al., 1986) may also comprise many 
individual virions, again consistent with the ID50 being high in terms of virions. Thus, 
although Haas et al., (1993) estimated the risk of infection from one pfu of rotavirus 
to be 27%, that pfu may comprise thousands of virions. This is not inconsistent with 
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the results of Bull et al. (2012) for NoV which suggest the ID50 is in the order of 
7,000 virions since only 0.01% can get through the bottleneck and initiate infection. 
Thus, if the probability of infection by a virion is 0.0001, then according to the 
negative exponential dose response model about 7,000 virions would be needed for a 
50% chance of infection. 
NGS data on the viral mutant spectrum give complementary information on some of 
the steps of the mechanistic infection process in Table 1. Thus, Bull et al. (2012) 
speculate that only a few NoV variants can bind to HBGA in step 2 effectively 
filtering out the majority of NoV variants in an exposure (representing a bottleneck). 
Indeed, the minor variant transmitted differed from the dominant donor variant in an 
amino acid change directly adjacent to the primary HBGA binding site in the capsid. 
For HIV, the variants responsible for establishing infection in a new host have unique 
phenotypic properties that contribute to the establishment of infection with specific 
amino acids that increase viral entry efficiency (step 3) as well as unique 
glycosylation patterns that aid attachment to host receptors (step 2) (Bull et al., 2012). 
Thus a challenge for developing a mechanistic DRR for initial infection is 
determining which variants are important for a given step (Table 1). 
APPLYING OMICS TO THE MODELLING OF DISEASE PROGRESSION 
ONCE INITIAL INFECTION HAS OCCURRED 
Central to disease progression and viral pathogenesis by RNA viruses is the fidelity of 
replication by RdRp (Domingo et al., 2008; Smidansky et al., 2008) which controls 
the complexity of the mutant spectrum produced from step 4. The spreading of PV, 
for example, to the nervous system is secondary to the initial establishment of 
infection in the gastrointestinal tract. Thus PV titres peak in the small intestine and 
brain at day 1 and 5, respectively (Vignuzzi et al. 2006). Different individual progeny 
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viruses in the mutant spectrum have different cell and tissue tropisms reflecting their 
specific gene sequences compared to the original infecting virus. Specifically, a PV 
mutant with a high fidelity RdRp (i.e. produces a reduced range of variants) replicated 
in the small intestine, kidney and spleen but failed to reach the brain and spinal cord 
and to produce neuropathology in mice (Vignuzzi et al. 2006). However, restoration 
of the standard mutant spectrum complexity by subjecting the mutant PV to chemical 
mutagenesis led to a neuropathogenic mutant spectrum with the virus reaching the 
brain and spinal cord (Vignuzzi et al. 2006; Smidansky et al., 2008). Thus, enhanced 
opportunities for co-operation between more diverse clades of mutant spectra (arising 
from the high mutation rates) IDFLOLWDWHWKHYLUXV¶Vreaching specific target organs, 
thereby increasing viral loads and chances of transmission. However, too much 
genotypic variability may retard the progress of the virus infection by producing too 
many defective variants (Smidansky et al., 2008). A conclusion of Smidansky et al. 
(2008) is that RdRp fidelity is tuned by natural selection to achieve the optimal 
genotypic diversity in the mutant spectrum and, consequently, viral competitiveness 
in the dynamic and hostile environment of the host cell. Furthermore, the level of 
diversity and type of diversity needed may change in different tissues as different host 
challenges are encountered. It may also change during the infection cycle and may 
vary depending on the route of transmission (Wright et al., 2011; Bull et al., 2012). 
Bull et al., (2012) speculate that deep sequencing may yet identify differences 
between NoV transmitted through faeces compared to those in vomitus, for example. 
The huge complexity of the interactions together with the lack of understanding of 
how RdRp controls fidelity at the molecular level (Smidansky et al., 2008) severely 
limit prediction of disease progression. A further complication is that the host 
response to pathogen is also dynamic with the host HBGA specificity to NoV 
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changing over time (Lindesmith et al., 2008) together with changes in host mucin 
glycosylation during rotavirus infection such that the mucins become more potent in 
inhibiting the virus (Boshuizen et al., 2005).  
The element of chance in disease progression 
There is also evidence that disease progression could to a certain extent depend on 
chance (i.e. it is probabilistic). Thus deep-sequencing has shown that FMDV may take 
different evolutionary trajectories even within the same cow, albeit in different 
isolated compartments, namely the front left foot vs. the back right foot (Wright et al., 
2011). This specifically confounds prediction for the individual host. 
Viral markers of virulence 
Although it is not possible at present to interpret pathogenic potential from viral gene 
sequences, there are examples of markers in the virus sequence known to be 
associated with disease-related traits. Thus, the amino acid threonine at residue 
position 33 in RdRp is associated with pandemic potential in NoV GII (Eden et al., 
2011) and in the case of FMDV in cattle, an amino acid change in one of the four 
capsid proteins is associated with persistent infection (Horsington and Zhang 2007). 
Identification of such markers may enable more broad predictions to be made about 
disease potential in a population.  
Host markers of resistance 
Genetic markers on the host may give an indication of resistance to disease 
progression through being able to mount an effective immune response. For example, 
understanding polymorphisms in the PRR genes (Wang et al., 2011) and human 
leukocyte antigens (HLA) genes (Hoof et al., 2012) together with interferon coding 
regions (Thomas et al., 2009) may indicate the proportion of the population able to 
mount more effective responses to an RNA virus such as HCV. The HLA proteins 
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present viral peptides to the T cells in the acquired immune response and it is well 
documented that individual persons differ in their HLA proteins and that some are 
more protective than others against viruses including HIV (Wang et al., 2012), HCV, 
hepatitis B virus and herpes simplex type 1 virus. Hoof et al. (2012) found that 
protective HLA molecules show a preference to present peptide fragments from 
conserved HCV proteins (e.g. Core and NS5B), while non-protective HLA molecules 
preferentially target HCV proteins that are significantly less conserved (e.g. NS5A). 
Taken together, their analysis suggests that by targeting the most constrained, and 
WKHUHE\FRQVHUYHGSDUWVRIWKH+&9JHQRPH³SURWHFWLYH´+/$PROHFXOHVUHGXFHWKH
potential of HCV to escape the cytotoxic T cell response of the infected host. Thus it 
may be possible to predict viral clearance from the type of viral protein which is 
presented by the HLA. Carlsson et al. (2009) identified capsid residues in NoV that 
are evolutionarily conserved. X-ray crystallography structures are available for human 
HLA molecules bound to viral peptides including SARS coronavirus (Roder et al., 
2008a) and other studies for swine leukocyte antigen (the porcine HLA equivalent) 
complexed with peptides from 2009 pandemic H1N1 influenza virus or Ebola virus 
have recently been published (Zhang et al., 2011). However, predicting whether 
conserved or less conserved peptide fragments are presented by the HLA and the 
effectiveness of viral peptide presentation for the purpose of estimating disease 
progression will be difficult. An additional problem is that glycans play a role in 
antigen presentation by the HLA, with glycosylation perhaps fine-tuning the binding 
properties (Ryan and Cobb 2012).  
Viral countermeasures 
Some viral proteins target the HLA proteins and interfere with antigen presentation 
(Roder et al., 2008b). Other viral countermeasures in disease progression include the 
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ability of the NoV capsid to evolve to evade the memory immune response and escape 
from herd immunity while retaining its ability to bind any of several HBGAs 
(Donaldson et al., 2008). Thus, many individuals are susceptible to reinfection by 
NoV (Lindesmith et al., 2010). NGS of viral sequences may allow identification of 
immune escape mutations which impair the ability of both T cell responses and 
neutralizing antibodies to maintain immune control as shown for HIV-1 (Henn et al., 
2012). These rapid, low frequency viral variants are not detected by conventional 
sequencing approaches and demonstrate the application of genomics in understanding 
the dynamic interplay in immune control. Some viruses, e.g. porcine reproductive and 
respiratory syndrome virus (PRRSV), prevent the protective immune response by 
suppressing of certain host genes. As an example of the use of transcriptomics, 
Wysocki et al. (2012) compared differences in RNAs from lungs of high and low 
PRRSV burden pigs and found that in high burden pigs, expression of cellular genes 
associated with host protection was delayed. 
DISCUSSION 
This review summarises some of the potential applications of omics approaches to 
developing DRRs for infection through the oral route by RNA viruses, with a view to 
better defining the role of omics data in MRA. While some specific issues of the DRR 
can be addressed by omics data (e.g. estimating resistant/susceptible ratios in the 
host), there are clearly other areas where substantial progress in our understanding of 
the molecular interactions is required before omics data can be applied to MRA (if 
they can ever be applied).  
Although viruses have far fewer genes than bacterial pathogens, the nature of the 
mutant spectrum in the case of RNA viruses greatly complicates the application of 
omics approaches to the development of mechanistic dose response models. This is 
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compounded by the fact that the frequencies of some important variants that initiate 
infection are as low as 0.01% as in the case of NoV and HCV (Bull et al., 2012; 
Wang et al., 2010), raising the question of which sequence to look at in terms of 
specific interactions with the host. Here, the initial infection process in the 
gastrointestinal tract has been broken down into four mechanistic steps (Table 1). The 
breadth of the fields considered in these steps demonstrates the need for a 
multidisciplinary approach including not only omics data but also conventional 
biochemistry and molecular biology inputs which provide detail on the molecular 
components of each step. Thus, currently protein structure determination by 
crystallography studies underpins our understanding of the specific molecular 
interactions (e.g. PRR with PAMP ligands in step 1 or NoV capsid binding to HBGA 
in step 2). The overall conclusion is that the molecular mechanisms of each step in 
Table 1 are not sufficiently well understood at present to enable quantitative 
estimation of probabilities on the basis of omics data. However, omics approaches 
will make a major contribution to specific areas of the initital infection process in 
particular in accommodating genetic variation both in the pathogen and the host 
population through extensive sequencing. The human microbiome should be included 
here too because the gastrointestinal microbiota play a major role in protection against 
infection in step 1, although the molecular mechanisms are not established. Genome 
sequencing for individual humans enables identification of genetic differences 
between susceptible and non-susceptible persons and it may be possible in future to 
tailor risk assessment to different host populations in terms of genetic susceptibility to 
initial infection. A promising application of such genetic markers is to define the 
proportion of the host population which is more susceptible to initial infection by a 
specific pathogen. Current examples include the FUT2 gene which affects NoV 
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binding in the gastrointestinal tract in step 2 and potentially polymorphisms in the 
host PRR genes in step 1 (Wang et al., 2011). Thus the great strength of genome 
sequencing is in giving information on the distribution and proportion of susceptible 
genotypes in the host population rather than in predicting specificities of interactions 
from the amino acid sequences concurrently obtained. Indeed, even for the best 
characterised step in the infection process, namely NoV capsid/HBGA binding for 
step 2, changes in amino acid sequence cannot be used to predict changes in binding 
specificity and affinity. Furthermore, not only are there many gaps in our 
understanding of how the few viral proteins actually function and interact with host 
cell proteins but also there are often multiple mechanisms and alternative molecular 
pathways used by the virus, e.g. inhibition of host gene expression and translation by 
SARS coronavirus (Lokugamage et al., 2012). The potential of proteomics 
approaches is in contributing to our understanding of how the few viral proteins 
interact with a multitude of cellular proteins within the host cell particularly in step 4.  
Host glycans play a central role in the pathogen infection process including binding of 
virus to specific receptors in steps 1 and 2 and also in the immune system. The 
example with HBGA glycans in NoV binding (step 2) is simple in the sense that a 
single mutation in a gene (the FUT2 gene coding for the enzyme that synthesizes 
HBGA) results in the absence of a functional receptor. However, not all relationships 
involving glycans and omics data are as simple as this and the link between a single 
mutation in a protein-coding gene and susceptibility to infection may be the exception 
rather than the rule. Glycans have complex structures which may be changed during 
infection as the host tries to evade the pathogen, and also during development of the 
host (McGuckin et al., 2011). Prediction of glycan structures from DNA sequences is 
not possible currently, and unlike gene expression, it is not clear how cells control 
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glycan structures. Thus our current understanding of glycoproteomics and glycan 
function is a major limitation in developing a mechanistic DRR for viruses. 
The ultimate aim in the application of omics and molecular biology approaches would 
be in taking the DRR beyond the classic volunteer-derived model for infection in a 
broad group of (typically) healthy individuals into the realms of predicting disease 
progression and morbidity at the individual host level, based on the genetic 
information of the host and virus. However, although genomics approaches may 
enable consideration of the virus as a dynamic and evolving system, as opposed to a 
static single entity within the infected host, predicting the progression of an RNA 
virus in terms of its ability to spread to new tissues (e.g. nervous system) or to evade 
the host acquired immune system and so persist, resulting in chronic infection is 
fraught with difficulties. This is due to both the complexity of the pathways and the 
nature of how variants in the RNA virus mutant spectrum interact. Thus the variants 
collectively and cooperatively contribute to the characteristics of the viral population 
and can express different phenotypic traits such that our ability to predict the outcome 
of an infection is limited (Lauring and Andino 2010). However, interaction of mutant 
spectra could help elucidate in the future the mechanisms by which higher exposure 
doses increase the probability of illness, given infection has occurred. Thus for NoV, 
Teunis et al. (2008) reported that infected subjects had a dose-dependent probability 
of becoming ill, ranging from 0.1 (at a dose of 103 genomes) to 0.7 (at 108 genomes). 
Genomics data should increase our repertoire of genetic markers both in the host and 
virus giving better understanding of those factors affecting disease progression. 
As an alternative to attempting to use omics data to develop a mechanistic DRR, NGS 
may provide empirical data for calibrating a DRR. Thus, the data obtained by NGS of 
virus in donor and recipient hosts (e.g. that obtained for NoV by Bull et al. 2012) 
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show great promise for directly estimating the probability of infection by a virion 
while avoiding the uncertainties associated with the role of viral proteins, glycan 
interactions and mutant spectra. NGS of virus in donor and recipient provides a 
unique insight into the infection process in terms of the frequency of the variant which 
initiated infection and demonstrated in the case of NoV that 99.99% of virions, 
including the major variants, do not initiate infection (Bull et al., 2012). This suggests 
most of the virions in an exposure have a very low probability of infection. NGS has 
shown that different virions in a high dose exposure have different sequences and 
some are better adapted at initiating infection than others (Bull et al., 2012). 
In conlusion, it is anticipated that omics approaches can make a contribution to 
specific areas of the initial infection process. The emphasis will be on omics 
approaches, together with traditional biochemistry techniques, as a tool to understand 
more fully the mechanisms of each step in the initial infection process, although it 
seems certain that it will be an extremely difficult task to interpret this information 
quantitatively. Genomics data will continue to give information on the frequency of 
genes affecting susceptibility to initial infection within the host population. Lack of 
knowledge on glycans together with difficulties in predicting the functional effects of 
amino acid changes in key proteins pose challenges. It is concluded that predicting 
disease progression (given initial infection has occurred) for RNA viruses at the level 
of the individual host is not possible. This reflects the lack of understanding in 
variability of the virus, evolution of the virus during progression of the disease, co-
operation between different clades of mutant spectra and the countermeasures by both 
the host and virus, together with chance factors. However, molecular markers in the 
host and virus may provide useful information on disease progression for risk 
assessment. The potential use of NGS to compare mutant spectra of viruses in the 
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exposure dose presented by the infected donor and in the infected recipient as a 
method to give direct estimates of probability of infection should be explored further. 
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Table 1: Breakdown of the initial infection process into four steps for building a mechanistic dose 
response relationship for RNA viruses through the oral route: Information needs. 
Step Description Current information gaps and 
understanding requirements 
1 Overcoming initial host defences 
including mucus barrier, the microbiome, 
decoy receptors and the innate immune 
system to reach the cellular receptor in the 
gastrointestinal tract* 
Mechanism of disocciation of 
virus from the decoy receptor and 
mucus, changes in glycosylation. 
Mechanisms of microbial 
interference. 
2 Binding of virion to its cellular receptor in 
the grastrointestinal tract 
Predicting specificity of glycan 
binding by viruses. Genetic 
markers of resistance and 
frequency of specific alleles in 
host population 
3 Entry of virion to the host cell Better understanding on 
proteolytic cleavage of viral 
proteins by host cell proteases 
4 Replication of the virus in the infected 
cells (to give a mutant cloud) and capsid 
assembly 
Proteomics may facilitate 
identification of host protein/virus 
protein interactions that control 
the regulatory pathways within the 
infected cell 
*Microbiome includes the indigenous bacteria in the gastrointestinal tract and decoy 
receptors are host molecules which mop up viruses before they reach their target cells. 
